Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma (Q44351254)

2 December 2017

title

Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma (English)

1 reference

2 December 2017

9

1 reference

2 December 2017

4

Mattsson J

1 reference

2 December 2017

Hentschke P

1

1 reference

2 December 2017

Barkholt L

2

1 reference

2 December 2017

Uzunel M

3

1 reference

2 December 2017

Wersäll P

5

1 reference

2 December 2017

Pisa P

6

1 reference

2 December 2017

Martola J

7

1 reference

2 December 2017

Albiin N

8

1 reference

2 December 2017

Söderberg M

10

1 reference

2 December 2017

Remberger M

11

1 reference

2 December 2017

Thörne A

12

1 reference

2 December 2017

Ringdén O

13

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Bone Marrow Transplantation

2 December 2017

published in

1 reference

2 December 2017

volume

31

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

253-261

1 reference

The role of the immune system in anti-tumour responses. Potential for drug therapy

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

Bone-marrow transplantation (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

Allogeneic bone marrow transplantation for hematological malignancies--controversies and recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

Mixed chimerism: preclinical studies and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

Graft-versus-tumour and graft-versus-leukaemia effect in patient with concurrent breast cancer and acute myelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

CMV PCR monitoring in leucocytes of transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

A graft-versus-colonic cancer effect of allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703811

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703811

1 reference

2 December 2017

1 reference